Amrize Ltd AMRZ 深 滬
交易中 09-23 09:58:55 美东时间
50.58
+0.060
+0.12%
華盛通- 最 高51.26
- 今 開50.69
- 成交量 13.57万股
- 最 低 50.57
- 昨 收 50.52
- 總市值 279.71亿
- 52周最高 56.2899
- 市盈率 靜 21.94
- 換手率 0.02%
- 52周最低 44.12
- 委 比 -88.09%
- 總股本 5.53亿
- 歷史最高 56.2899
- 量 比 0.34
- 振 幅 1.37%
- 歷史最低 44.12
- 每 手 1
- 風險率 1.80%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多New Buy Rating for Amrize Ltd (AMRZ), the Basic Materials Giant
Truist Financial analyst Keith Hughes reiterated a Buy rating on Amrize Ltd tod...
09-22 19:15
美股大行评级 | 潜在涨幅577.08%！Veritone获D. Boral Capital升目标价至26美元，维持"买入"评级
今日重点评级关注：D. Boral Capital：维持Veritone"买入"评级，目标价从6美元升至26美元；Guggenheim：维持Dianthus Therapeutics"买入"评级，目标价从92美元升至100美元
09-10 18:01
Oppenheimer Initiates Coverage On Amrize with Outperform Rating, Announces Price Target of $62
Oppenheimer analyst Bryan Blair initiates coverage on Amrize (NYSE:AMRZ) with a Outperform rating and announces Price Target of $62.
09-09 20:18
Alpha Buying: Thin Insider Buying Makes These Recent Purchases Significant
I am still not seeing a lot of meaningful insider or institutional buying activ...
09-04 22:38
Amrize Advises Against TRC Capital’s Mini-Tender Offer
Amrize Ltd ( ($AMRZ) ) just unveiled an update. Amrize Ltd has advised its shar...
08-29 05:03
10 Analysts Assess Amrize: What You Need To Know
Amrize (NYSE:AMRZ) has been analyzed by 10 analysts in the last three months, r...
08-27 03:01
JP Morgan Maintains Overweight on Amrize, Raises Price Target to $60
JP Morgan analyst Adrian Huerta maintains Amrize (NYSE:AMRZ) with a Overweight and raises the price target from $52 to $60.
08-26 23:06
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
RBC Capital Maintains Outperform on Amrize, Lowers Price Target to $54
RBC Capital analyst Anthony Codling maintains Amrize (NYSE:AMRZ) with a Outperform and lowers the price target from $61 to $54.
08-09 01:19
